相似文献
1
Controlled trial of a thymic hormone extract (Thymostimulin) in 'autoimmune' chronic active hepatitis.
Gut. 1984 Mar;25(3):279-83. doi: 10.1136/gut.25.3.279.
2
In vitro effect of TP-1 (a calf thymic extract) on suppressor T-cell function of patients with autoimmune chronic active hepatitis.
Int J Immunopharmacol. 1988;10(6):651-6. doi: 10.1016/0192-0561(88)90018-5.
3
Effectiveness of thymostimulin treatment in hepatitis B surface antigen-positive chronic active liver disease. Results of a randomized clinical trial.
Arzneimittelforschung. 1985;35(8):1317-22.
4
Thymostimulin in the treatment of hepatitis B surface antigen-positive chronic active hepatitis. Controlled clinical trial--two years follow-up.
Arzneimittelforschung. 1987 Apr;37(4):450-6.
5
[Effects of a treatment with a thymus extract (thymostimulin) in acute viral hepatitis B in drug-dependent patients].
Boll Ist Sieroter Milan. 1984;63(6):519-28.
6
[Treatment of chronic active HBsAg-positive hepatitis with thymostimulin].
G Ital Chemioter. 1984 Jan-Aug;31(1-2):181-4.
7
Thymostimulin in malignant pleural effusions.
Int J Tissue React. 1984;6(1):53-5.
8
IgG production in 'autoimmune' chronic active hepatitis. Effect of prednisolone on T and B lymphocyte function.
Clin Exp Immunol. 1985 Aug;61(2):290-6.
9
A double-blind, placebo-controlled trial of thymostimulin in symptomatic HIV-infected patients.
AIDS. 1990 Jul;4(7):679-81. doi: 10.1097/00002030-199007000-00012.
10
[Clinical experience with thymostimulin (TP-1) therapy. Preliminary findings].
Minerva Med. 1986 Jun 23;77(26):1243-7.
引用本文的文献
1
Comparative efficacy and tolerability of treatments for adult autoimmune hepatitis: A systematic review and network meta-analysis.
Exp Ther Med. 2018 Jun;15(6):4838-4850. doi: 10.3892/etm.2018.6063. Epub 2018 Apr 13.
2
Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments.
World J Gastroenterol. 2017 Sep 7;23(33):6030-6048. doi: 10.3748/wjg.v23.i33.6030.
3
Drug therapy in the management of type 1 autoimmune hepatitis.
Drugs. 1999 Jan;57(1):49-68. doi: 10.2165/00003495-199957010-00005.
4
Infectious complications of liver disease.
J Gen Intern Med. 1993 Jun;8(6):327-32. doi: 10.1007/BF02600149.
5
Autoimmune hepatitis. Evolving concepts and treatment strategies.
Dig Dis Sci. 1995 Feb;40(2):435-56. doi: 10.1007/BF02065434.
6
Chronic active hepatitis.
Gut. 1991 Sep;Suppl(Suppl):S63-72. doi: 10.1136/gut.32.suppl.s63.
本文引用的文献
1
Improved radioimmunoassay technique for measuring serum thymopoietin.
Clin Chim Acta. 1980 Oct 23;107(1-2):111-9. doi: 10.1016/0009-8981(80)90420-9.
2
Treatment of cell-mediated immunodeficiency with calf thymic hormone (T.P.I.).
Pediatr Res. 1982 Jul;16(7):573-8. doi: 10.1203/00006450-198207000-00018.
3
Immunoregulation in autoimmunity.
J Allergy Clin Immunol. 1980 Jul;66(1):5-17. doi: 10.1016/0091-6749(80)90132-3.
4
Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis.
Hepatology. 1983 Sep-Oct;3(5):685-9. doi: 10.1002/hep.1840030510.
5
Histiocytosis-X.
N Engl J Med. 1981 Jan 15;304(3):146-53. doi: 10.1056/NEJM198101153040304.
6
Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings.
N Engl J Med. 1980 Aug 14;303(7):370-3. doi: 10.1056/NEJM198008143030704.
7
Maturational effects of thymic hormones on human helper and suppressor T cells: effects of FTS ('Facteur Thymique Sérique') and thymosin.
Clin Exp Immunol. 1980 Mar;39(3):722-7.
8
Effect of corticosteroids on suppressor-cell activity in "autoimmune" and viral chronic active hepatitis.
N Engl J Med. 1982 Nov 18;307(21):1301-4. doi: 10.1056/NEJM198211183072102.
9
Improvement of cellular immunity and IgA production in immunodeficient children after treatment with synthetic serum thymic factor (FTS).
Lancet. 1982 Aug 7;2(8293):293-7. doi: 10.1016/s0140-6736(82)90271-9.
10
Zotero 插件